19 research outputs found
Láser y luz pulsada intensa en el tratamiento de hemangiomas infantiles y malformaciones vasculares
The use of the indications of the laser in treating
vascular malformations and infantile haemangiomas is
based on the theory of selective photothermolysis, in
which the oxyhaemoglobin is the target chromophore
on which the light of the laser acts, thus avoiding damage
to neighbouring tissues. The pulsed dye laser is the
most employed and at present is the treatment of
choice in capillary malformations (port-wine stains). A
variable response is obtained, with a substantial clearing
of the colour of the lesion after several sessions.
Application at early ages seems to improve the results.
Venous malformations, especially those localised in
the mucosa, respond better to the Nd:YAG laser; lymphatic
malformations to the CO2 laser. Arteriovenous
malformations rarely respond. Use of the pulsed dye
laser in the phase of proliferation of the haemangiomas
is subject to controversy, except where there is ulceration.
A rapid re-epithelialization is obtained in these
cases following its use. In the involution phase,
patients with residual vascular lesions can benefit from
other lasers such as KTP or Nd:YAG. If they show an
atrophic surface and scars these complications
improve with the CO2 laser or Er:YAG. New treatment
modalities are emerging, such as photodynamic therapy,
whose efficacy and safety, both in the treatment of
haemangiomas and vascular malformations, have yet
to be confirmed
Reproductive parameters of Santa Inês ewes submitted to short-term treatment with re-used progesterone devices
Láser y luz pulsada intensa en el tratamiento de hemangiomas infantiles y malformaciones vasculares
The use of the indications of the laser in treating
vascular malformations and infantile haemangiomas is
based on the theory of selective photothermolysis, in
which the oxyhaemoglobin is the target chromophore
on which the light of the laser acts, thus avoiding damage
to neighbouring tissues. The pulsed dye laser is the
most employed and at present is the treatment of
choice in capillary malformations (port-wine stains). A
variable response is obtained, with a substantial clearing
of the colour of the lesion after several sessions.
Application at early ages seems to improve the results.
Venous malformations, especially those localised in
the mucosa, respond better to the Nd:YAG laser; lymphatic
malformations to the CO2 laser. Arteriovenous
malformations rarely respond. Use of the pulsed dye
laser in the phase of proliferation of the haemangiomas
is subject to controversy, except where there is ulceration.
A rapid re-epithelialization is obtained in these
cases following its use. In the involution phase,
patients with residual vascular lesions can benefit from
other lasers such as KTP or Nd:YAG. If they show an
atrophic surface and scars these complications
improve with the CO2 laser or Er:YAG. New treatment
modalities are emerging, such as photodynamic therapy,
whose efficacy and safety, both in the treatment of
haemangiomas and vascular malformations, have yet
to be confirmed
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
BACKGROUND, Primary cutaneous melanoma is often infiltrated by lymphocytes that provide the opportunity to study what may be the local immunologic reaction to the tumor and to correlate the presence of these lymphocytes with overall survival. In an attempt to delineate the histologic diagnostic criteria, to classify different categories of lymphocytic infiltrates, previously described by Elder et al. as brisk, nonbrisk, and absent, and to verify their prognostic significance, we reviewed 285 consecutive cases of primary cutaneous melanomas (American Joint Committee on Cancer Stage I and II).
METHODS, In addition to clinical variables (age, sex, and location of tumor) and the presence of tumor infiltrating lymphocytes in the vertical growth phase, the histopathologic attributes reviewed included mitotic rate, thickness, and regression. The results were derived from independent histopathologic review by two pathologists (C.G.C., M.C.M., Jr.) on separate occasions. A multivariate analysis of survival was performed with the Cox's regression model.
RESULTS. The 5- and 10-year survival rates for melanoma with a vertical growth phase and a brisk infiltrate were 77% and 55%, respectively. For tumors with a nonbrisk infiltrate, the 5- and 10-year survival rates were 53% and 45%, respectively, and for tumors with absent tumor infiltrating lymphocytes, the 5- and 10-year survival rates were 37% and 27%, respectively. Mitotic index, thickness, and tumor infiltrating lymphocytes were statistically (univariate analysis) significant prognostic factors (P = 0.003, 0.000001, 0.0003, respectively), whereas the presence or absence of regression is not. In the univariate statistical analysis, the sex of patients and site of melanoma also were statistically significant (P = 0.00001 and 0.002 respectively), whereas age (P = 0.98) was not statistically significant. The multivariate analysis of thickness, mitotic rate, and tumor infiltrating lymphocytes showed chat thickness and presence of tumor infiltrating lymphocytes were significant and independent histologic prognostic factors. With regard to the clinical factors, sex retained its independent prognostic significance. The histologic characteristics of melanoma with vertical growth phase (brisk, nonbrisk, and absent) are exemplified.
CONCLUSIONS. We demonstrated that when categories of tumor infiltrating lymphocytes are strictly defined, they indeed have very strong predictive value for primary cutaneous melanomas with a vertical growth phase. This work confirms the work of Clark et al. and fully illustrates the brisk, nonbrisk, and absent categories of infiltration. Finally, a multivariate analysis comparing thickness, mitotic rate and presence of tumor infiltrating lymphocytes showed that only thickness and presence of tumor infiltrating lymphocytes are significant and independent positive histologic prognostic factors
Large agminated cellular 'plaque-type' blue nevus surrounding the ear: a case and review.
Large or giant cellular blue nevi are usually congenital and represent a challenge for the physician. Close anatomic structures may be altered by the size of the moles. In this article, we report the case of an uncommon large, agminated, cellular blue nevus of the 'plaque type' in a 42-year-old female. Due to the risks of malignant melanoma development on a large or giant blue nevus, we highlight the importance of proper histopathological diagnosis. Furthermore, because of the possibility that the nevus may invade the bone and cerebral tissues, we discuss the indication of a radiological diagnosis. The accurate correlation to clinical and histopathological findings and appropriate multidisciplinary management can save the lives of patients. © 2013 S. Karger AG, Basel
Recommended from our members
Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser
Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser
BACKGROUND: The recurrence of port-wine stain (PWS) blood vessels by pulsed dye laser (PDL)-induced angiogenesis is a critical barrier that must be overcome to achieve a better therapeutic outcome. OBJECTIVES: To determine whether PDL-induced angiogenesis can be suppressed by topical axitinib. METHODS: The mRNA expression profiles of 86 angiogenic genes and phosphorylation levels of extracellular signal regulated kinases (ERKs), phosphorylated protein kinase B (AKT) and ribosomal protein S6 kinase (p70S6K) in rodent skin were examined with or without topical axitinib administration after PDL exposure. RESULTS: The PDL-induced increased transcriptional levels of angiogenic genes peaked at days 3–7 post-PDL exposure. Topical application of 0.5% axitinib effectively suppressed the PDL-induced increase in mRNA levels of the examined angiogenic genes and activation of AKT, P70S6K and ERK from days 1 to 7 post-PDL exposure. After topical administration, axitinib penetrated into rodent skin to an approximate depth of 929.5 μm. CONCLUSIONS: Topical application of 0.5% axitinib can systematically suppress the PDL-induced early stages of angiogenesis via inhibition of the AKT/mammalian target of rapamycin/p70S6K and Src homology 2 domain containing transforming protein-1/mitogen-activated protein kinase kinase/ERK pathway cascades